BamSEC and AlphaSense Join Forces
Learn More

Spyre Therapeutics Inc.

NASDAQ: SYRE    
Share price (10/4/24): $29.15    
Market cap (10/4/24): $1.481 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2023
M&A Revised 06/23/23 Aeglea BioTherapeutics, Inc. - M&A Call 06/22/23
CY 2022
Other Revised 10/27/22 Aeglea BioTherapeutics, Inc. - Special Call 10/27/22 Other Revised 02/03/22 Aeglea BioTherapeutics, Inc. - Special Call 02/03/22 Other Revised 01/12/22 Aeglea BioTherapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 10:30 AM 01/12/22
CY 2021
Other Revised 12/06/21 Aeglea BioTherapeutics, Inc. - Special Call 12/06/21 Other Revised 06/08/21 Aeglea BioTherapeutics, Inc. - Shareholder/Analyst Call 06/08/21 Other Revised 01/13/21 Aeglea BioTherapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM 01/13/21
CY 2020
Other Revised 06/08/20 Aeglea BioTherapeutics, Inc. - Shareholder/Analyst Call 06/08/20 Other Revised 01/15/20 Aeglea BioTherapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 02:30 PM 01/15/20
CY 2019
Other Revised 09/03/19 Aeglea BioTherapeutics, Inc. - Special Call 09/03/19 Other Revised 04/08/19 Aeglea BioTherapeutics, Inc. - Special Call 04/08/19 Earnings Revised 03/07/19 Aeglea BioTherapeutics, Inc., Q4 2018 Earnings Call, Mar 07, 2019 03/07/19
CY 2018
Other Revised 12/11/18 Aeglea BioTherapeutics, Inc. - Special Call 12/11/18 Other Revised 10/17/18 Aeglea BioTherapeutics, Inc. - Special Call 10/17/18 Other Revised 09/04/18 Aeglea BioTherapeutics, Inc. - Special Call 09/04/18 Other Revised 05/22/18 Aeglea BioTherapeutics, Inc. Presents at 2018 UBS Global Healthcare Conference, May-22-2018 08:30 AM 05/22/18 Other Revised 04/12/18 Aeglea BioTherapeutics, Inc. - Special Call 04/12/18 Earnings Revised 03/13/18 Aeglea Biotherapeutics, Inc., Q4 2017 Earnings Call, Mar 13, 2018 03/13/18